News1 week ago
EMRIS Pharma, the Recent Spin-off of Hadasit and Yissum, Launches the Development of a New Innovative topical drug for the Treatment of Skin Toxicities, Improving Treatment and Quality of Life for Cancer Patients USA – English Israel – English
A novel approach to treating skin toxicities caused by EGFRi, based on a decade of research by leading Israeli cancer researchers JERUSALEM, June 8, 2023 /PRNewswire/...
